ADC Control Human IgG1-vcMMAF provides a human IgG1-based control antibody-drug conjugate containing a valine-citrulline (vc) linker and monomethyl auristatin F (MMAF) payload and specifically supports ADC assay development, cytotoxicity studies, linker-payload evaluation, and comparative ADC research.
Key Features and Benefits
- Human IgG1 Control ADC: Provides an IgG1-based conjugate specifically for control and comparative studies in ADC research.
- vcMMAF Linker-Payload: Combines a valine-citrulline linker with the microtubule-disrupting payload MMAF.
- MMAF Payload: Contains monomethyl auristatin F, a potent antimitotic payload commonly studied in ADC development.
- Cleavable Linker: The vc linker supports protease-mediated cleavage and intracellular payload release.
- ADC Control Platform: Provides a useful comparator specifically for evaluating target-specific ADCs and experimental conjugates.
- Assay Development: Supports optimization of ADC cytotoxicity, uptake, stability, and cell-based assay conditions.
- Comparative Research: Enables evaluation of antibody targeting effects, linker performance, and payload-dependent activity.
Applications
- ADC Control Studies: Provides a control conjugate for comparison with target-specific antibody-drug conjugates.
- ADC Assay Development: Supports development and optimization of cell-based and biochemical ADC assays.
- Cytotoxicity Research: Useful for evaluating MMAF-associated cellular effects and ADC-dependent cytotoxicity.
- Linker-Payload Research: Supports investigation of vc linker behavior, payload release, and MMAF activity.
- Comparative ADC Research: Especially useful for comparing experimental ADCs with an IgG1-vcMMAF control.
- Mechanism-of-Action Studies: Supports investigation of microtubule disruption and payload-mediated cellular responses.
- Oncology Research: Useful as a control reagent in experimental cancer and ADC research models.
Storage and Handling
- Storage: Store according to the product specification under recommended temperature conditions. Protect from excessive heat and repeated freeze-thaw cycles.
- Handling: Handle using appropriate procedures for antibody-drug conjugates and cytotoxic research materials. Maintain conditions that preserve antibody and conjugate stability.
ADC Control Human IgG1-vcMMAF provides an IgG1-based control ADC containing a vc linker and MMAF payload and specifically supports ADC assay development, cytotoxicity studies, linker-payload evaluation, and comparative oncology research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
